GMI Asthma and COPD Market: Global Industry Analysis, | Page 2

Anti-inflammatory drugs segment includes anti-leukotrienes, monoclonal antibodies,
and corticosteroids. Corticosteroids dominated the segment in 2016, due to increased
usage in corticosteroids for COPD and associated advantages with inhaled
corticosteroid (ICS) such as high topical force in the direction of decreasing
inflammation in low and lung systemic motion.
Inhalers includes metered dose inhalers (MDIs), soft mist inhalers (SMIs), and drug
powder inhalers (DPIs). DPIs accounted for major share in 2016 due to the advantages
such as less patient coordination required, compactness, appropriate for emergency
circumstances, and portability are some aspects that encourages the patients’ buying
preferences.
U.S. led the asthma and COPD market owing to strong pipeline for novel therapies,
technological advancements, and growing disease prevalence. According to, the CDC, in
2014, around 15.7 million Americans were detected with COPD, that accounts for 6.4%
people of the total population. India and China are growing significantly due to increase
in disease prevalence. These nations have opportunity to grow their business rapidly as
some of the European pharmaceutical companies are on the edge of expiration in terms
of numerous patents.
Some of the industry players include F. Hoffmann-La Roche, Boehringer Ingelheim,
Cipla, Aurobindo, GlaxoSmithKline, AstraZeneca, Novartis, Ranbaxy, Merck, Pfizer,
Glenmark, Abbott, Dr. Reddy’s Laboratories, Nycomed, Amgen, Mylan, Vectura,
AptarGroup, Actavis, and Sunovion. The industry players focus on strategic alliances,
mergers, and enhanced combination drugs, usage of biologics, as well as personalization
in treatment upsurges business growth. For instance, in May 2016, AstraZeneca
announced positive results for the benralizumab, potential novel medicine with phase
III programme for severe asthma.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom research
reports along with growth consulting services. Our business intelligence and industry
research reports offer clients with penetrative insights and actionable market data
specially designed and presented to aid strategic decision making. These exhaustive
reports are designed via a proprietary research methodology and are available for key
industries such as chemicals, advanced materials, technology, renewable energy and
biotechnology.
Contact Us:
2 | Page